During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.Below are the ratings of the most accurate analysts for three high-yield ...

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint that was filed against CVS on July 12, 2024 with a Class Period from May 3, 2023 to April 30, 2024. Our investigation concerns whether the board of directors of CVS have breached their fiduciary duties to the company. CVS is a healthcare ...

JHVEPhoto/iStock Editorial via Getty Images Introduction: An old saw for value investors is, 'First they get cheap, then they go down.' If you look at the previous articles on (NYSE:CVS) dating back over a year, that statement might keep coming to mind. This was a stock that kept coming up on value screens I'd run, but I never bit until now. The negatives that kept me out can also be seen in the more recent articles, where authors have downgraded their view or punted completely. Fundamentals were deteri ...

CVS Health (CVS) ended the recent trading session at $57.98, demonstrating a +0.78% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.54%. At the same time, the Dow added 0.72%, and the tech-heavy Nasdaq gained 0.65%.Coming into today, shares of the drugstore chain and pharmacy benefits manager had lost 0.05% in the past month. In that same time, the Retail-Wholesale sector gained 9.25%, while the S&P 500 gained 4.86%.Analysts and investors alike wi ...

CVS Health Corporation (CVS) recently introduced hormonal contraceptive prescribing service at CVS Pharmacy locations in Massachusetts. Under the service, a CVS pharmacist will evaluate women interested in receiving a birth control prescription and those who are clinically eligible will receive the same.With the latest launch, the company leaped toward lowering barriers that prevent women from getting the birth control they need. The initiative also helped address the disparities in contraceptive access for ...

CVS pharmacists can now evaluate patients and prescribe hormonal contraceptives WOONSOCKET, R.I., Sept. 12, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that CVS Pharmacy® locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients interested in receiving a birth control prescription can be evaluated by a CVS pharmacist and, if clinically eligible, receive a prescription for birth control.CVS pharmacist tests patient's blood pressureCVS pharmacist consul ...

WOONSOCKET, R.I., Sept. 10, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Tropical Storm Francine, which is expected to make landfall in Louisiana as a hurricane tomorrow. The company's priority is the health and safety of its customers, members and colleagues, and it is committed to providing communities with access to the products and services they need to plan for the storm.CVS Pharmacy® is reaching out to its patients by text message, email and phone to remind them to refill and ...

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS). Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=101234&from=3 CLASS PERIOD: ...

Sundry Photography CVS Health (NYSE:CVS) is a major, American pharmacy, with over 9,000 locations. Earlier this year, its stock took a big tumble after Q1 earnings disappointed. CVS 1Y Price History (Seeking Alpha) While some might have been scared by this, I believe most of the business is sound and that it has proved to be a steady compounder over time. With modest growth assumptions, CVS is priced to deliver attractive returns, which is why I rate it a Buy. Business Model CVS has three main reporting ...

SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CVS Health Corporation (NYSE: CVS) securities between May 3, 2023 and April 30, 2024, inclusive (the “Class Period”), have until this upcoming Tuesday, September 10, 2024 to seek appointment as lead plaintiff of the CVS class action lawsuit. Captioned Nixon v. CVS Health Corporation, No. 24-cv-05303 (S.D.N.Y.), the CVS class action lawsuit charges CVS and certain of CVS’s top current and ...